Iritero Injection – Uses, Strengths, Benefits & Side Effects

What Is Iritero Injection?

Iritero Injection is a prescription anticancer medicine containing irinotecan, a chemotherapy agent used in the treatment of colorectal cancer, including cancer of the colon and rectum. It works by interfering with an enzyme called topoisomerase I, which cancer cells need to replicate their DNA and multiply.

Iritero is administered by intravenous infusion under the supervision of qualified healthcare professionals. The treatment regimen, dosage and frequency depend on the patient's diagnosis, overall health, previous treatments and response to therapy.

Cordium Pharmaceuticals Pvt Ltd provides this product information to help healthcare professionals, pharmaceutical buyers and other interested readers understand the medicine's composition, applications and safety considerations.

Iritero Injection Strengths and Composition

Iritero product information lists the following presentations:

Iritero 40 mg/2 mL Injection

Iritero 100 mg/5 mL Injection

Each presentation contains irinotecan at a concentration of 20 mg/mL, as specified in the referenced product information. Availability, registration status, packaging and labelling may vary by country.

Healthcare professionals should verify the approved local product information before prescribing or administering the medicine.

Uses and Benefits of Iritero Injection

Iritero Injection is used as part of medically supervised chemotherapy for eligible patients with colorectal cancer. Depending on the clinical setting, irinotecan may be prescribed alone or alongside other anticancer medicines.

Potential treatment benefits include:

Cancer growth control: Helps inhibit the growth and multiplication of cancer cells.

DNA replication interference: Blocks topoisomerase I, an enzyme involved in DNA replication.

Combination treatment options: May form part of an established chemotherapy regimen selected by an oncologist.

Individualised treatment planning: Different vial strengths can support prescribed dosing requirements when selected by the treating healthcare team.

Treatment outcomes vary according to cancer type, disease stage, treatment regimen and individual patient factors. Iritero is not a guaranteed cure, and its suitability must be determined by an oncology specialist.

Iritero Injection Side Effects

Like other chemotherapy medicines, Iritero Injection can cause side effects. Commonly reported effects include:

Diarrhoea

Nausea and vomiting

Abdominal discomfort or pain

Fatigue and weakness

Hair loss

Reduced appetite

Anaemia and low white blood cell counts

Fever and increased susceptibility to infections

Important safety warning: Severe diarrhoea and serious reductions in white blood cells can occur. Contact the treating oncology team immediately for persistent or severe diarrhoea, fever, signs of infection or dehydration. Seek urgent medical attention for severe symptoms.

Patients should disclose their medical history, current medicines, pregnancy status and any liver or kidney problems to their healthcare professional. Pregnancy and breastfeeding require specific medical assessment. Regular blood tests and clinical monitoring are essential during treatment.

Frequently Asked Questions About Iritero Injection

1. What is Iritero Injection used for?

Iritero Injection contains irinotecan and is used in prescribed chemotherapy regimens for colorectal cancer.

2. What strengths of Iritero Injection are available?

Referenced product information lists 40 mg/2 mL, 100 mg/5 mL and 300 mg/15 mL presentations. Confirm local availability before ordering.

3. How is Iritero Injection administered?

It is administered by intravenous infusion by trained healthcare professionals. Patients must not self-administer this medicine.

4. What are the common side effects of Iritero Injection?

Diarrhoea, nausea, vomiting, fatigue, hair loss and changes in blood cell counts are among the reported side effects.

5. Can Iritero Injection be used without a prescription?

No. It is a prescription chemotherapy medicine that requires specialist supervision and appropriate patient monitoring.

6. How can pharmaceutical buyers enquire about Iritero Injection?

Authorised healthcare providers and pharmaceutical buyers can contact Cordium Pharmaceuticals Pvt Ltd to enquire about product documentation, supply availability, applicable registrations and export requirements, subject to verification.

Product Enquiries

For Iritero Injection product information, documentation and pharmaceutical supply enquiries, contact Cordium Pharmaceuticals Pvt Ltd through its official business channels. Product availability, supply terms and destination-country regulatory requirements must be confirmed before any transaction.

Medical disclaimer: This page is for educational and product-information purposes only. It does not replace professional medical advice, prescribing information or an oncologist's treatment recommendations.